Profile
Brian Sheridan - Operating Partner
Brian joined ArchiMed in 2018.
He has more than 20 years advising in life sciences companies, and 10 years as a non-executive director in healthcare companies at various stages of evolution.
Brian qualified as a British Barrister, subsequently practicing in Brussels with US law firm Oppenheimer, Wolff & Donnelly LLP, as a Partner in its Life Sciences Practice Group.
Brian is the author of ‘Biotechnology Law and Practice’ (Palladian, 1998), and has acted as a strategic advisor to numerous multinationals across the medical device, diagnostics, pharmaceutical and biotechnology sectors.
Between 2003 and 2017, Brian was General Counsel, Chief Compliance Officer and Company Secretary to Sorin Group, and thereafter LivaNova PLC.
In addition to heading the Legal and Compliance Departments, Brian played a central role in the design and execution of the Company’s wide-ranging M&A strategy, as well as leading the Company’s Blue Ocean Strategy Team.
Brian has a long-standing relationship with other ArchiMed partners, for close to fifteen years.
He is currently a non-executive Director in the Italy-headquartered Hospital Delivery specialist BOMI.
At ArchiMed, Brian is particularly focused on the Medtech and Biopharma sectors.
Brian obtained his Law Degree, Masters Degree and Diploma in Advanced Competition Law from the University of London.
Brian is a British citizen.
Brian Sheridan active positions
| Companies | Position | Start |
|---|---|---|
Bar Standards Board | Corporate Officer/Principal | - |
Bar of England & Wales
Bar of England & Wales Miscellaneous Commercial ServicesCommercial Services Engages in representing barristers in England and Wales | Corporate Officer/Principal | - |
Former positions of Brian Sheridan
| Companies | Position | End |
|---|---|---|
ArchiMed SAS
ArchiMed SAS Investment ManagersFinance ArchiMed invests in small and middle-sized companies located across the globe. The firm targets companies operating in the field of the healthcare sector. It participates in growth and buyout transactions with an investment size of EUR 10 - 1000 million. The firm makes follow-on investments. | Private Equity Investor | 2023-03-30 |
| LIVANOVA PLC | General Counsel | - |
| CYBERONICS, INC. | Director/Board Member | - |
| SORIN SPA | General Counsel | - |
Training of Brian Sheridan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
LivaNova USA, Inc.
LivaNova USA, Inc. Medical SpecialtiesHealth Technology Engages in design, development, sale and marketing of implantable medical devices | Health Technology |
Sorin SpA
Sorin SpA Medical SpecialtiesHealth Technology Develops, manufactures, and markets products for cardiovascular care | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bar of England & Wales
Bar of England & Wales Miscellaneous Commercial ServicesCommercial Services Engages in representing barristers in England and Wales | Commercial Services |
ArchiMed SAS
ArchiMed SAS Investment ManagersFinance ArchiMed invests in small and middle-sized companies located across the globe. The firm targets companies operating in the field of the healthcare sector. It participates in growth and buyout transactions with an investment size of EUR 10 - 1000 million. The firm makes follow-on investments. | Finance |
Bar Standards Board | |
LivaNova Plc
LivaNova Plc Medical SpecialtiesHealth Technology Develops electrotherapeutic devices | Health Technology |
- Stock Market
- Insiders
- Brian Sheridan
















